A 2021 update : approach to asthma management in adults

Loading...
Thumbnail Image

Authors

Schellack, Natalie
Truter, A.
Ntuli, P.N.
Mokwele, N.
Mogale, K.
Esterhuizen, A.

Journal Title

Journal ISSN

Volume Title

Publisher

Medpharm Publications

Abstract

Asthma is a chronic inflammatory disease that causes hyper-responsiveness of the bronchial tree, with reversible airflow obstruction. The condition places a significant burden on our healthcare system. Chronic asthma can cause remodelling of the airway. Patients suffering from asthma should be aware of the signs and symptoms thereof, as well as the factors that can precipitate an asthmatic attack. Asthma is mostly classified as either acute or chronic; the diagnosis of asthma is based on identifying both a characteristic pattern of respiratory symptoms and variable expiratory airflow limitation. Treatment is based on how the patient presents and includes bronchodilators, inhaled corticosteroids and mast cell stabilisers. This article provides an overview of the diagnosis, characterisation and treatment of asthma.

Description

Keywords

Asthma, Bronchodilator, Inhaled corticosteroid, β-agonist, Spirometry, Peak expiratory flow, Short-acting β2-agonist (SABA), Long-acting β2-agonist (LABA)

Sustainable Development Goals

Citation

Schellack, N., Truter, A., Ntuli, P. N. et al. 2021, 'A 2021 update : approach to asthma management in adults', SA Pharmaceutical Journal, vol. 88, no. 4, pp. 17-24, doi : 10.520/ejc-mp_sapj_v88_n4_a6.